Home › Funds › Avidity Partners Management LP › ELVN

Avidity Partners Management LP position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Avidity Partners Management LP reported holding 550,000 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$27.9M, representing 4.47% of its reported portfolio and ranking #5 among its reported holdings. Avidity Partners Management LP has disclosed ELVN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)550.00K sh
Reported value held$27.91M
Portfolio Weight4.47%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's ELVN position evolved

Avidity Partners Management LP first disclosed a stake in ELVN in Q1 2025 at 11,300 shares (US$222K). The position peaked in Q2 2026 at 550,000 shares, worth US$27.9M. Across 6 filings, Avidity Partners Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 550,000 shares valued at US$27.9M — an increase of 150,000 shares quarter over quarter.. Notable position changes include a 1142% increase in Q3 2025 (shares fell 25% over the following quarter), a 185% increase in Q1 2026 (shares rose 29% over the following quarter), a 38% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 11.30K $222.38K New
Q2 2025 11.30K $226.68K Hold
Q3 2025 140.30K $2.87M Add
Q4 2025 140.30K $2.16M Hold
Q1 2026 400.00K $15.68M Add
Q2 2026 550.00K $27.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Avidity Partners Management LP held ELVN?

Avidity Partners Management LP has disclosed ELVN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Avidity Partners Management LP's current position in ELVN?

As of Q2 2026, Avidity Partners Management LP holds 550.00K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $27.91M, representing 4.47% of its reported portfolio and ranking #5.

Has Avidity Partners Management LP been buying or selling ELVN?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP increased its position in ELVN. The position peaked in Q2 2026 at 550.00K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.